Accendra Health officer proposes 33,161-share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Accendra Health Inc (ACH) officer Perry Bernocchi reported a proposed sale of 33,161 common shares, with an aggregate market value of $4,048.97, on an approximate sale date of November 16, 2026. The shares are listed as acquired through restricted stock vesting on May 11, 2023 (11,625 shares), May 15, 2023 (12,355 shares), and March 20, 2025 (9,181 shares). The notice gives August 14, 2026 as the date of plan adoption or instruction, if relying on Rule 10b5-1.
Key Figures
Key Terms
Rule 10b5-1 regulatory
Restricted Stock Vesting financial
Aggregate Market Value financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.